Joined Today: 0

AIS Antares Pharma, Stock Message Board

All Messages

AIS Message Board Home | Join The AIS Group |

#24: AIS Stock News : Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin® (Human Growth Hormone)
TheMachine	June 30, 2009 08:28:21 AM
New patient-friendly option to be made available for Tev-TropinTeva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and its partner, Antares Pharma, Inc. (NYSE Amex: AIS) today announced the approval... view message ignore post recommend post

#23: Antares Pharma to Present at the BMO Capital Markets Healthcare Conference
TheMachine	July 21, 2008 07:25:14 AM
Antares Pharma, Inc. (AMEX:AIS), a specialty pharmaceutical company focused on improving pharmaceuticals through advanced drug delivery systems, today announced that... view message ignore post recommend post

#22: Antares Pharma Receives Milestone Payment
Stock News Bot	December 22, 2007 05:01:40 AM
Additional Potential of $10 Million in Sales Based Milestones Antares Pharma, Inc. (AMEX: AIS) announced that the Company has received an additional milestone payment of... view message ignore post recommend post

#21: AIS News Antares Pharma Reports Fourth Quarter and Year End 2006 Financial Results
Stock News Bot	March 27, 2007 04:00:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) today reported financial and operating results for the fourth quarter and year ended December 31, 2006. FDA... view message ignore post recommend post

#20: AIS News Antares Receives $1.75 Million Milestone Payment
Stock News Bot	March 26, 2007 05:11:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (AMEX:AIS) today announced that the Company has received a $1.75 million milestone payment of $2.6 million due in 2007 from Bradley... view message ignore post recommend post

#19: AIS News Antares Pharma Secures $10MM Credit Facility
Stock News Bot	February 28, 2007 04:50:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced today that is has closed on a secured credit facility consisting of two term loans in the aggregate principal... view message ignore post recommend post

#18: AIS News Antares Pharma Announces Notice of Allowance for Newest ATD(TM) Gel Patent
Stock News Bot	February 21, 2007 04:50:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced receipt of Notice of Allowance from the United States Patent & Trademark Office (USPTO)... view message ignore post recommend post

#17: AIS News Antares Pharma Announces the Addition of Leonard S. Jacob, M.D., Ph.D. to the Board of Directors
Stock News Bot	January 17, 2007 11:00:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) has elected Leonard S. Jacob, M.D., Ph.D. to the Company’s Board of Directors. Dr. Leonard Jacob joins... view message ignore post recommend post

#16: AIS News Antares ATD(TM) Formulation Enters Phase III Study
Stock News Bot	January 2, 2007 06:56:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced that its development partner BioSante Pharmaceuticals has initiated a Phase III safety and efficacy trial of... view message ignore post recommend post

#15: AIS News Antares Receives First FDA Approval of ATD(TM) Gel Platform
Stock News Bot	December 18, 2006 09:46:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex: AIS) announced the U.S. Food and Drug Administration (FDA) approved for marketing Elestrin™ (formerly Bio-E-Gel®)... view message ignore post recommend post

#14: AIS News Antares Pharma Signs EasyTec(TM) ODT Agreement
Stock News Bot	November 28, 2006 04:50:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced the signing of a feasibility and development agreement with an unnamed multi-national pharmaceutical partner... view message ignore post recommend post

#13: AIS News Antares Pharma to Present at BMO Capital Markets Focus on Healthcare 2006 Investor Conference
Stock News Bot	November 27, 2006 01:00:00 PM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced that Jack E. Stover, President & Chief Executive Officer is scheduled to present at the BMO Focus on ... view message ignore post recommend post

#12: AIS News Antares Pharma Reports Third Quarter 2006 Financial Results
Stock News Bot	November 14, 2006 04:50:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex: AIS) today reported financial results for the three and nine months ended September 30, 2006. Total revenues were... view message ignore post recommend post

#11: AIS News Antares Receives Milestone Payment from Bradley Pharmaceuticals
Stock News Bot	November 8, 2006 11:37:00 AM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) today announced that the Company has received an $875,000 milestone payment from Bradley Pharmaceuticals Inc. (NYSE:BDY)... view message ignore post recommend post

#10: AIS News Antares Pharma to Present at CIBC World Markets Seventeenth Annual Healthcare Conference
Stock News Bot	November 1, 2006 12:50:00 PM
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced that Jack E. Stover, President & Chief Executive Officer is scheduled to present at the CIBC World Markets... view message ignore post recommend post

Group Home | Login if you want to post a message